Navigation Links
Fat Reduction Market in Europe to Soar Despite Economic Downturn
Date:7/16/2009

WALTHAM, Mass., July 16 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the fat reduction device market will experience the highest growth of all body contouring devices in Europe through 2013. MRG's European Markets for Body Contouring Devices 2009 report finds that the fat reduction segment will be fueled by physician adoption of newer modalities like transdermal ultrasound and laser, light, and energy fat reduction devices, which offer patients less invasive solutions than traditional liposuction.

Transdermal ultrasound and laser-assisted liposuction (LAL) procedures will experience particularly strong growth over the next five years, with patient desire for minimally invasive procedures fueling both segments. Transdermal ultrasound procedures can be performed in an hour and without any incisions, allowing patients to return to their normal routine afterwards. Until recently, the market for transdermal ultrasound was dominated by UltraShape; however, the competitive landscape has changed with the launch of Medicis' LipoSonix in mid-2008, and it will continue to shift over the next five years as new firms enter the market in an attempt to capitalize on the rapid growth.

"The LAL market is undergoing similar competitive changes. As LAL continues to stimulate patient demand, physicians will purchase new LAL devices and new competitors will emerge in order to capitalize on the market's tremendous potential," says Kevin Flewwelling, Manager of the Aesthetics division at MRG. "DEKA's SmartLipo device was one of the first LAL devices available in the European market; however, many competitors have since launched LAL devices, including Cynosure, Eleme Medical, Sciton, Syneron, and others."

MRG's European Markets for Body Contouring Devices 2009 report covers the markets for cellulite reduction, skin tightening, fat reduction, and gastric bands in France, Germany, Italy, Spain, and the UK. The report provides full breakdowns of body contouring procedures by type as well as device unit sales by subtype, including five-year forecasts, up-to-date market shares, and in-depth qualitative insights.

About Millennium Research Group

Millennium Research Group (www.MRG.net), a Decision Resources, Inc. company (www.DecisionResourcesInc.com), is the global authority on medical technology market intelligence and the leading provider of strategic information to the health care sector. The company provides specialized industry expertise through multiclient market research, ongoing Marketrack(TM) projects, customer loyalty tracking, facility-level procedure forecasting, and customized solutions.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the health care industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

    For more information, contact:

    Amy Krohn
    Millennium Research Group
    416-364-7776 x101
    akrohn@mrg.net

    Elizabeth Marshall
    Decision Resources Inc.
    781-296-2563
    emarshall@dresources.com


'/>"/>
SOURCE Millennium Research Group
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Federal Judge Orders Schwarzenegger Administration to Comply with Order That Blocks State Reduction for IHSS Worker Wages
2. Caraco Pharmaceutical Laboratories, Ltd. Announces an Indefinite Reduction in its Workforce
3. Hospital Bedside Technology Solution Results in 74 Percent Reduction in Heart Failure Readmission Rate
4. Employees Increasingly Accept and Understand Reductions in Health Plan Benefits and Premium-Cost Sharing
5. Studies Show Groundbreaking 22% Reduction in Depression Symptoms in 4 Hours
6. Maricopa Integrated Health System Reports 90 Percent Reduction in Pressure Ulcers
7. Pharmaceutical Companies Seek to Balance Quality Assurance & Cost Reduction
8. AstraZeneca Studies Show Relief of Nighttime Heartburn and Reduction in GERD-Related Sleep Disturbances
9. New study finds Power Plate exercise aids in weight loss, reduction of harmful visceral fat
10. New Study Finds Power Plate(R) Exercise Aids in Weight Loss, Reduction of Harmful Visceral Fat
11. Massive decline in rates of coronary death in Iceland are largely attributed to risk factor reductions in the population
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... April 29, 2016 , ... A new ... with severe congenital diaphragmatic hernia have better survival rates if surgery is performed ... (CDH)—a condition where the diaphragm fails to form completely, letting abdominal organs into ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... won the $30,000 Perlman Grand Prize of the 2016 Wharton Business Plan ... the Michelson People’s Choice Award, and the Committee Award for Most ‘Wow Factor,’ ...
(Date:4/29/2016)... NY (PRWEB) , ... April 29, 2016 , ... ... and engineer of patented products, announces the Gyrociser, an exercise invention which aids ... worth $2 billion," says Scott Cooper, CEO and Creative Director of World Patent ...
(Date:4/29/2016)... ... April 29, 2016 , ... Melanoma is the deadliest type of skin cancer. Although only about ... of skin cancer deaths. More than 10,000 people are expected to die of melanoma this ... it is the one of the most commonly diagnosed cancers in young women. A recent ...
(Date:4/29/2016)... ... , ... New York City based oral and maxillofacial surgeon Dr. Majid Jamali is ... treat obstructive sleep apnea. Dr. Jamali is proud to offer this permanent solution to patients ... or both jaw bones. This surgery is performed to correct the alignment of the jaw. ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... April 28, 2016 New ... 2016" is a report that provides an overview ... R&D pipelines by identifying new targets and MOAs ... Company Profiles discussed in this H1 2016 Osteoarthritis ... Srl, AbbVie Inc., Abiogen Pharma S.p.A., Ablynx NV, ...
(Date:4/27/2016)... 2016 Im ... Zürich gab Strekin AG den Start einer ... Erhaltung des Resthörvermögens von Patienten, denen ein ... umfassende Phase-II-Doppelblindstudie mit Placebo-Kontrollgruppe werden momentan Patienten ... während der Operation direkt ins Mittelohr verabreicht. ...
(Date:4/27/2016)... , April 27, 2016 ... Including 42% Growth in Recurring Consumable Sales  ... Mauna Kea Technologies (Euronext: MKEA, OTCQX: MKEAY) inventor ... announced its sales for the first quarter ended March ... and the execution of its commercial strategy. ...
Breaking Medicine Technology: